Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

NOIP: The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)

National Institutes of Health

Note: This is a Forecasted Opportunity.

The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to develop, operate, and sustain a cloud-based data storage and computing platform that democratizes access to large-scale Alzheimer’s disease (AD) and AD-related dementias (ADRD) genetic and genomic data. The platform must be secure, scalable, and interoperable. The platform will support the NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS), the primary NIA-supported repository for the archiving and distribution of human genetic data related to AD/ADRD. The purpose of the platform will be to:

Enable efficient ingestion, curation, harmonization, and analysis of multi-ancestry, large population-scale datasets;
Provide robust analysis, visualization, and artificial intelligence -ready resources within secure cloud workspaces;
Ensure compliance with federal security and data-sharing policies;
Promote interoperability with other NIH- and NIA-supported repositories; and
Provide user support, training, and community engagement.

The NOFO aims to foster collaboration, accelerate discovery, and maximize the scientific value and impact of AD/ADRD genetics research for the broader research community.

By improving data accessibility, interoperability, reporting, reproducibility, and scalable computational systems that enable rigorous, reproducible, and transparent research, the NOFO seeks to align with the NIH’s plan for Gold Standard Science and the AD/ADRD Research Implementation Milestones . Additionally, the NOFO seeks to address the Academies of Sciences, Engineering, and Medicine's recommendation of ensuring broad, secure access to high-value datasets and enhancing data usability to maximize the return on research investments and support future discoveries in AD/ADRD. Moreover, the NOFO intends to directly advance NIA’s Strategic Directions , particularly Goal G to support the infrastructure and resources necessary for high-quality research, by strengthening data sharing, computational infrastructure, and research rigor across the AD/ADRD community.

Estimated Post Date:

Sep 01, 2026

Estimated Application Due Date:

Nov 01, 2026

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type: Government/Federal

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity